2772-7076

IJID Regions

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 921 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact921 DOIs
2

Attach ORCID iDs across 166 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact166 DOIs
3

Deposit reference lists for 74 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact74 DOIs

DOIs for this ISSN

Showing the top 5 of 921 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Lessons and updates from India's National Tuberculosis Elimi… (10.1016/j.ijregi.2025.100599)
Abstract ORCID
71.57 26
2 Carbapenem-resistant Acinetobacter baumannii infections: Ant… (10.1016/j.ijregi.2023.10.007)
Abstract ORCID
62.76 17
3 Bacterial contamination rates and drug susceptibility patter… (10.1016/j.ijregi.2021.09.005)
Abstract ORCID
61.52 16
4 HIV and adolescent girls and young women in sub‐Saharan Afri… (10.1016/j.ijregi.2022.08.009)
Abstract
54.03 144
5 The 2023 – 2024 multi-source mpox outbreaks of Clade I MPXV… (10.1016/j.ijregi.2024.100397)
Abstract ORCID
53.96 11
6 Hookworm infection induces glycometabolic modulation in Sout… (10.1016/j.ijregi.2023.08.009)
Abstract ORCID
52.07 10
7 Inequities underlie the alarming resurgence of Tuberculosis… (10.1016/j.ijregi.2025.100587)
Abstract ORCID
52.07 10
8 Magnitude of tuberculosis and its associated factors among u… (10.1016/j.ijregi.2022.04.008)
Abstract ORCID
50.00 9
9 Tuberculosis outcomes among international migrants living in… (10.1016/j.ijregi.2024.100564)
Abstract ORCID
47.71 8
10 Secondary infections modify the overall course of hospitaliz… (10.1016/j.ijregi.2022.02.008)
Abstract ORCID
45.15 7
11 A systematic review of the effectiveness and cost-effectiven… (10.1016/j.ijregi.2025.100666)
Abstract ORCID
45.15 7
12 Global landmark: 2023 marks the worst year for dengue cases… (10.1016/j.ijregi.2024.100459)
Abstract
44.98 62
13 First confirmed case of infant botulism caused by Clostridiu… (10.1016/j.ijregi.2022.08.003)
Abstract ORCID
42.25 6
14 Genetic features of SARS-CoV-2 Alpha, Delta, and Omicron var… (10.1016/j.ijregi.2024.03.003)
Abstract ORCID
42.25 6
15 Clinical presentation, genotypic diversity, and intracellula… (10.1016/j.ijregi.2025.100690)
Abstract ORCID
42.25 6
16 Twenty-five years of Nipah outbreaks in Southeast Asia: A pe… (10.1016/j.ijregi.2024.100434)
Abstract
41.09 43
17 New estimation of the prevalence of chronic pulmonary asperg… (10.1016/j.ijregi.2022.11.005)
Abstract
40.84 42
18 Factors influencing adherence to antiretroviral therapy amon… (10.1016/j.ijregi.2022.04.009)
Abstract
40.05 39
19 Ten public health strategies to control the Covid-19 pandemi… (10.1016/j.ijregi.2021.09.003)
Abstract
38.91 35
20 High rate of transmission in a pulmonary tuberculosis outbre… (10.1016/j.ijregi.2021.10.012)
Abstract ORCID
38.91 5
21 Genetic diversity and drug resistance profiles of Mycobacter… (10.1016/j.ijregi.2022.06.005)
Abstract ORCID
38.91 5
22 Antimicrobial resistance – A global problem in need of globa… (10.1016/j.ijregi.2023.10.005)
Abstract ORCID
38.91 5
23 Oropouche virus: A re-emerging arbovirus of clinical signifi… (10.1016/j.ijregi.2024.100456)
Abstract ORCID
38.91 5
24 Effect of short-term ambient temperature exposure on influen… (10.1016/j.ijregi.2024.100479)
Abstract ORCID
38.91 5
25 Epidemiology and mortality outcome of carbapenem- and colist… (10.1016/j.ijregi.2023.01.002)
Abstract
38.29 33
26 Large outbreak of Crimean-Congo haemorrhagic fever in Iraq,… (10.1016/j.ijregi.2023.01.007)
Abstract
38.29 33
27 Value of urine-based lipoarabinomannan (LAM) antigen tests f… (10.1016/j.ijregi.2022.06.004)
Abstract
37.96 32
28 A case of suicide during the 2017 monkeypox outbreak in Nige… (10.1016/j.ijregi.2022.04.004)
Abstract
37.28 30
29 Late HIV diagnosis among migrant women living in Europe — a… (10.1016/j.ijregi.2023.03.006)
Abstract
37.28 30
30 Sociodemographic determinants of use and misuse of antibioti… (10.1016/j.ijregi.2023.01.001)
Abstract
36.18 27
31 A critical review of mpox outbreaks, risk factors, and preve… (10.1016/j.ijregi.2024.100402)
Abstract
35.78 26
32 Mortality-associated clinical risk factors in patients with… (10.1016/j.ijregi.2021.09.002)
Abstract
35.37 25
33 Clinical profile and early severity predictors of dengue fev… (10.1016/j.ijregi.2023.09.001)
Abstract
35.37 25
34 Alarming update on incidence of Crimean-Congo hemorrhagic fe… (10.1016/j.ijregi.2023.11.018)
Abstract
35.37 25
35 Lung abnormalities on computed tomography of Vietnamese pati… (10.1016/j.ijregi.2024.01.006)
Abstract ORCID
34.95 4
36 Molecular characteristics of antimicrobial resistance and bi… (10.1016/j.ijregi.2025.100646)
Abstract ORCID
34.95 4
37 Emerging lineages A2.2.1 and A2.2.2 of human metapneumovirus… (10.1016/j.ijregi.2024.100486)
Abstract
34.51 23
38 Severe maternal morbidity and mortality during the COVID-19… (10.1016/j.ijregi.2022.11.004)
Abstract
34.04 22
39 Seroprevalence of Hepatitis B virus infection and associated… (10.1016/j.ijregi.2023.01.009)
Abstract
33.56 21
40 COVID-19 vaccine acceptance among healthcare workers in the… (10.1016/j.ijregi.2021.08.003)
Abstract
33.06 20
41 Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a n… (10.1016/j.ijregi.2022.02.007)
Abstract
33.06 20
42 Epidemiology of urinary tract infection in adults caused by… (10.1016/j.ijregi.2022.05.001)
Abstract
33.06 20
43 Seroprevalence of SARS-CoV-2 antibodies in Bangladesh relate… (10.1016/j.ijregi.2022.01.013)
Abstract
32.53 19
44 Burden of COVID-19 and case fatality rate in Pune, India: an… (10.1016/j.ijregi.2021.12.006)
Abstract
31.97 18
45 Methicillin-resistant Staphylococcus aureus antibiotic susce… (10.1016/j.ijregi.2022.03.015)
Abstract
31.97 18
46 Factors associated with treatment delay and outcome in commu… (10.1016/j.ijregi.2023.03.013)
Abstract
31.97 18
47 Burden, causation, and particularities of Long COVID in Afri… (10.1016/j.ijregi.2023.08.004)
Abstract
31.97 18
48 COVID-19 inpatient treatments and outcomes during the confli… (10.1016/j.ijregi.2022.12.009)
Abstract
31.38 17
49 Co-occurrence of tuberculosis and diabetes mellitus, and ass… (10.1016/j.ijregi.2021.10.004)
Abstract
30.10 15
50 Adverse events of Oxford/AstraZeneca's COVID-19 vaccine amon… (10.1016/j.ijregi.2021.10.013)
Abstract
30.10 15